• Explore /
  • Poster
  • / Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.

Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.

Abstract Poster

Authors

Makenzi Evangelist

Makenzi Colleen Evangelist

US Oncology Research/New York Oncology Hematology, Albany, NY

Makenzi Colleen Evangelist , James Edward Butrynski , John C. Paschold , Patrick J. Ward , Alexander I. Spira , Kashif Ali , Janet L. Espirito , David Hakimian , Robert M. Jotte , Beth Koselke , Timothy Larson , Michael W. Meshad , Marcus A. Neubauer , Katie Ogden , Rami Owera , Donald A. Richards , Nicholas J. Robert , Jennifer M. Walberg , Yunfei Wang , Robert L. Coleman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9109)

DOI

10.1200/JCO.2023.41.16_suppl.9109

Abstract #

9109

Poster Bd #

97

Abstract Disclosures

Similar Posters

First Author: Mo Yang

First Author: Benjamin J. Solomon

First Author: Samuel Crawford

First Author: John Leonard Fox